These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 8090664)

  • 21. [Clinical and metabolic effects of erythropoietin administration in hemodialyzed children].
    Dyras P; Pietrzyk JA; Sancewicz-Pach K; Lenik J
    Przegl Lek; 1996; 53(11):793-6. PubMed ID: 9173441
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Iron stores in patients with chronic kidney failure treated with recombinant human erythropoietin].
    Cermák J; Gregora E; Lachmanová J; Brabec V
    Vnitr Lek; 1994 Mar; 40(3):174-8. PubMed ID: 8184571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The adverse effects of recombinant human erythropoietin therapy.
    Wong KC; Li PK; Lui SF; Nicholls MG; Lai KN
    Adverse Drug React Acute Poisoning Rev; 1990; 9(4):183-206. PubMed ID: 2088088
    [No Abstract]   [Full Text] [Related]  

  • 24. Prevalence and severity of anemia in pediatric hemodialysis patients.
    Azhir A; Nasiri J; Gheisari A
    Saudi Med J; 2007 Feb; 28(2):249-53. PubMed ID: 17268705
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of low dose recombinant human omega erythropoietin (rHuEPO) on anaemia in patients on hemodialysis.
    Acharya VN; Sinha DK; Almeida AF; Pathare AV
    J Assoc Physicians India; 1995 Aug; 43(8):539-42. PubMed ID: 8772973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Iron supplementation during erythropoietin therapy in patients on hemodialysis].
    Svára F; Sulková S; Kvasnićka J; Polakovic V
    Vnitr Lek; 1996 Dec; 42(12):849-52. PubMed ID: 9072885
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Anemia in chronic renal insufficiency--case report].
    Popović M
    Med Pregl; 1999; 52(6-8):279-81. PubMed ID: 10518388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The treatment of renal anemia].
    Koch KM
    Verh Dtsch Ges Inn Med; 1989; 95():246-8. PubMed ID: 2603482
    [No Abstract]   [Full Text] [Related]  

  • 29. Recombinant human erythropoietin (rhEPO) treatment potentiates growth hormone (GH) response to growth hormone releasing hormone (GHRH) stimulation in hemodialysis patients.
    Cremagnani L; Cantalamessa L; Orsatti A; Vigna L; Vallino F; Buccianti G
    Clin Nephrol; 1993 May; 39(5):282-6. PubMed ID: 8513607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin treatment of erythropoietin-deficient anemia without renal disease during pregnancy.
    Harris SA; Payne G; Putman JM
    Obstet Gynecol; 1996 May; 87(5 Pt 2):812-4. PubMed ID: 8677097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of recombinant human erythropoietin for management of anemia in dogs and cats with renal failure.
    Cowgill LD; James KM; Levy JK; Browne JK; Miller A; Lobingier RT; Egrie JC
    J Am Vet Med Assoc; 1998 Feb; 212(4):521-8. PubMed ID: 9491159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of rHuEPO in treatment of uremic anemia prior to end-stage renal disease.
    Koene RA; Frenken LA
    Kidney Int Suppl; 1992 Oct; 38():S142-7. PubMed ID: 1405365
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of erythropoietin on lymphocyte and granulocyte functions in dialyzed patients].
    Bartůnková J; Fucíková T; Sulková S; Marecková H
    Cas Lek Cesk; 1989 Oct; 128(42):1332-5. PubMed ID: 2598245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical experience of recombinant human erythropoietin in uremic children: report of three cases.
    Chuang FR; Wu MS; Leu ML; Huang CC
    Changgeng Yi Xue Za Zhi; 1996 Mar; 19(1):71-6. PubMed ID: 8935379
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Factors limiting the correction of anemia with recombinant human erythropoietin].
    Casati S
    Minerva Urol Nefrol; 1991; 43(3):121-3. PubMed ID: 1817332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Therapeutic use of recombinant human erythropoietin in clinical practice].
    Scudla V
    Vnitr Lek; 1995 Mar; 41(3):210-4. PubMed ID: 7762184
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Disorders of red blood cell production in uremia.
    Eschbach JW; Adamson JW; Cook JD
    Arch Intern Med; 1970 Nov; 126(5):812-5. PubMed ID: 5475703
    [No Abstract]   [Full Text] [Related]  

  • 38. [Influence of erythropoietin produced in vitro on experimental uremic anemia].
    Hu R
    Zhonghua Yi Xue Za Zhi; 1990 Sep; 70(9):522-4. PubMed ID: 1964859
    [No Abstract]   [Full Text] [Related]  

  • 39. [The after effect of r-HuEPO in treating anemic hemodialysis patients].
    Chu JQ
    Zhonghua Hu Li Za Zhi; 1994 Feb; 29(2):78-9. PubMed ID: 7788758
    [No Abstract]   [Full Text] [Related]  

  • 40. Erythropoietin therapy in peritoneal dialysis patients.
    Morris AT; Ronco C
    Perit Dial Int; 2000; 20 Suppl 2():S178-82. PubMed ID: 10911666
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.